Literature DB >> 30906624

The role of cholesterol metabolism in cancer.

Xiao Ding1, Weihua Zhang2, Song Li1, Hui Yang1.   

Abstract

Cholesterol plays an important role in cancer development. Both clinical and experimental studies have found that hypercholesterolemia and a high-fat high-cholesterol diet can affect cancer development. External cholesterol can directly activate the oncogenic Hedgehog pathway, and internal cholesterol can induce mTORC1 signaling. Cholesterol is a key component of lipid rafts, which are the major platforms for signaling regulation in cancer, and chelating membrane cholesterol is an effective anti-cancer strategy that disrupts the functions of lipid rafts. Cholesterol metabolism is often reprogrammed in cancer cells. Targeting cholesterol metabolism as a new therapeutic approach has received increasing attention. Here, we summarize some key molecular mechanisms supporting the use of anti-cholesterol therapy for cancer treatment.

Entities:  

Keywords:  Cancer; cholesterol; metabolism; oncogenic signaling

Year:  2019        PMID: 30906624      PMCID: PMC6405981     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  70 in total

1.  The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth.

Authors:  Yayun Liang; Cynthia Besch-Williford; Salman M Hyder
Journal:  Breast Cancer Res Treat       Date:  2022-01-17       Impact factor: 4.872

Review 2.  Lipid metabolism reprogramming in renal cell carcinoma.

Authors:  Gioia Heravi; Omid Yazdanpanah; Izabela Podgorski; Larry H Matherly; Wanqing Liu
Journal:  Cancer Metastasis Rev       Date:  2021-11-06       Impact factor: 9.264

3.  Validation of Human Sterol 14α-Demethylase (CYP51) Druggability: Structure-Guided Design, Synthesis, and Evaluation of Stoichiometric, Functionally Irreversible Inhibitors.

Authors:  Laura Friggeri; Tatiana Y Hargrove; Zdzislaw Wawrzak; F Peter Guengerich; Galina I Lepesheva
Journal:  J Med Chem       Date:  2019-11-11       Impact factor: 7.446

Review 4.  APOA1: a Protein with Multiple Therapeutic Functions.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Curr Atheroscler Rep       Date:  2021-02-16       Impact factor: 5.113

5.  HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma.

Authors:  Jiajun Huang; Xiaoyu Zhao; Xiang Li; Jiwei Peng; Weihao Yang; Shengli Mi
Journal:  PLoS Biol       Date:  2021-04-27       Impact factor: 8.029

6.  Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study.

Authors:  Abdullah K Altwairgi; Waleed A Alghareeb; Fouad H AlNajjar; Hussain Alhussain; Eyad Alsaeed; Ali Abdullah O Balbaid; Sadeq Aldanan; Yasser Orz; Abdullah A Alsharm
Journal:  Invest New Drugs       Date:  2020-08-27       Impact factor: 3.850

Review 7.  Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.

Authors:  Kush K Patel; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2021-06-12       Impact factor: 5.858

8.  Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer.

Authors:  Nurul Syuhada Ishak; Hanif Abdul Rahman; Shirley H F Lee; Shir Kiong Lu; Lin Naing
Journal:  J Gastrointest Cancer       Date:  2021-01-04

Review 9.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

10.  Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment.

Authors:  Jingtao Tong; Yifei Mao; Ziru Yang; Quan Xu; Zhen Zheng; Hui Zhang; Jingjing Wang; Sandian Zhang; Weibo Rong; Lu Zheng
Journal:  Cancer Manag Res       Date:  2021-05-18       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.